KRT13 and prostate cancer: These comparisons allowed us draw the following conclusions: 1) There are remarkable similarities between KRT13- and RANKL-expressing prostate cancer cells; both of these cells share common genes associated with survival-, EMT-, stemness-, neuroendocrine-, and developmental phenotypes (Figure 5).